Business profile
Global pharmaceutical company making generics, active ingredients and branded medicines, with large US and India businesses.
SectorPharma
CountryIndia
Listed onNSE, BSE
Latest quarterQ2 FY27
Latest results · Q2 FY27
Revenue₹8,671.00 cr
−1.5% YoY
Net profit₹913.40 cr
−36.0% YoY
Quarterly results
| ₹ crore | Q2 FY26 | Q2 FY27 |
|---|---|---|
| Revenue | ~8,803 | 8,671 |
| Net profit | ~1,427 | 913 |
| Profit margin | ~16.2% | 10.5% |
| Revenue growth YoY | — | −1.5% |
| Profit growth YoY | — | −36.0% |
~ approximate: worked out from the reported year-on-year growth, not a reported figure.
OneTrader reports
- Top Q2 Earnings: Infosys, Adani Power, Dr Reddy’s and More
- Sensex, Nifty Closing Today, October 26, 2026: Sensex Gains 483 Points, Nifty Reclaims 22,750 as Indian Markets Rebound
- Stocks to Watch Today: October 26, 2026 – Infosys, Kotak Bank, Coforge and More
- Sensex, Nifty Today, October 23: IT Gains Fail to Prevent Broad Market Decline
- Stocks to Watch Today: October 23, 2026 – Infosys, BPCL, JSW Steel, Coforge and More
- Stocks to Watch Today: Biocon, Tega Industries, Jupiter Wagons, RVNL and More — September 11, 2026
- Gland Pharma The Injectable Pharma Giant Entering Its Next Growth Cycle?
- Stocks to Watch Today: 10 Indian Stocks in Focus on August 17, 2026
More in Pharma
Anlon HealthcareCiplaGland PharmaMankind PharmaMorepen LaboratoriesOneSource Specialty PharmaPiramal Pharma
India figures in ₹ crore. YoY = change versus the same quarter last year. Figures are taken from company results as reported in OneTrader articles. For information only, not investment advice.